Julie currently serves as Director of Clinical Operations and is responsible for the strategic planning and oversight of Oncology clinical trials across Canada. Julie is also responsible for the development of client project proposals, and is a member of Scimega’s Board of Directors.
She joined Scimega in 2013 and brings over 10 years of scientific and clinical research experience to the team. Julie’s past professional experience includes planning, oversight, and monitoring of oncology clinical trials at investigative health centers across North America. She holds a Master’s degree in Biochemistry from the University of Montreal, where she studied the regulation of β-estrogen receptors by transcription factors SCL/Tal-1 in the context of breast cancer.
She also holds a Masters of Business Administration from Concordia University. Julie is a member of the Society of Clinical Research Associates (SoCRA).